Iskemik ve Toksik Akut Tübüler Nekroz Patofizyolojisi

1. Lameire NH, Vanholder R. Pathophysiology of ischaemic acute renal failure. Best Pract Res Clin Anaesthesiol 2004; 18:21-36.
2. Liano F, Pascual J. Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group. Kidney Int 1996;50:811-8.
3. Castaneda MP, Swiatecka-Urban A, Mitsnefes MM, Feuerstein D, Kaskel FJ, Tellis V, Devarajan P. Activation of mitochond-rial apoptotic pathways in human renal allografts after ische-mia-reperfusion injury. Transplantation 2003;76:50-4.
4. Jefferson A, Zager RA. Causes of acute renal failure. In: John¬son RJ, Feehally J (Eds), Comprehensive Clinical Nephrology,
2nd ed. London, Mosby, 2004, pp 207-224.
5. Oken DE. Hemodynamic basis for human acute renal failure (vasomotor nephropathy). Am J Med 1984;76:702-10.
6. Lieberthal W. Biology of acute renal failure: Therapeutic implications. Kidney Int 1997;52:1102-15.
7. Schwartz D, Blantz RC. Nitric oxide, sepsis, and the kidney. Semin Nephrol 1999;19:272-6.
8. Sutton TA, Molitoris BA. Mechanisms of cellular injury in isc-
hemic acute renal failure. Semin Nephrol 1998;18:490-7.
9. Kwon O, Nelson WJ, Sibley R, et al. Backleak, tight junctions, and cell- cell adhesion in postischemic injury to the renal al-
lograft. J Clin Invest 1998;101:2054-64.
10. Conger JD, Weil JV. Abnormal vascular function following isc-hemia-reperfusion injury. J Investig Med 1995;43(5):431-42.
11. Schrier RW, Wang W, Poole B, Mitra A. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin In¬vest 2004;114:5-14.
12. Conger JD, Robinette JB, Schrier RW. Smooth muscle calcium and endothelium-derived relaxing factor in the abnormal vascular responses of acute renal failure. J Clin Invest 1988;82: 532-7.
13. Chan L, Chittinandana A, Shapiro JI, Shanley PF, Schrier RW. Effect of an endothelin-receptor antagonist on ischemic acu¬te renal failure. Am J Physiol 1994;266:F135-8.
14. Sutton TA, Mang HE, Campos SB, Sandoval RM, Yoder MC,
Molitoris BA. Injury of the renal microvascular endothelium alters barrier function after ischemia. Am J Physiol Renal Physiol 2003;285:F191-8.
15. Klingebiel T, von Gise H, Bohle A. Morphometric studies on acute renal failure in humans during the oligoanuric and pol-yuric phases. Clin Nephrol 1983;20:1-10.
16. Mason J, Torhorst J, Welsch J. Role of the medullary perfusi-on defect in the pathogenesis of ischemic renal failure. Kid¬ney Int 1984;26:283-93.
17. Molitoris BA, Marrs J. The role of cell adhesion molecules in ischemic acute renal failure. Am J Med 1999;106:583-92.
18. Kelly KJ, Williams WW Jr, Colvin RB, Bonventre JV. Antibody
to intercellular adhesion molecule 1 protects the kidney aga¬inst ischemic injury. Proc Natl Acad Sci USA 1994;91:812-6.
19. Molitoris BA, Chan LK, Shapiro JI, Conger JD, Falk SA. Loss
of epithelial polarity: a novel hypothesis for reduced proxi¬mal tubule Na+ transport following ischemic injury. J Membr Biol 1989;107:119-27.
20. Kwon O, Phillips CL, Molitoris BA. Ischemia induces alterati¬ons in actin filaments in renal vascular smooth muscle cells.
Am J Physiol Renal Physiol 2002;282:F1012-9.
21. Edelstein CL, Wieder ED, Yaqoob MM, et al. The role of cysteine proteases in hypoxia-induced rat renal proximal tu¬bular injury. Proc Natl Acad Sci USA 1995;92:7662-6.
22. Alejandro VS, Nelson WJ, Huie P, et al. Postischemic injury, delayed function and Na+/K(+)-ATPase distribution in the
transplanted kidney. Kidney Int 1995;48:1308-15.
23. Oliver J, Macdowell M, Tracy A. The pathogenesis of acute renal failure associated with traumatic and toxic injury; renal ischemia, nephrotoxic damage and the ischemic episode. J
Clin Invest 1951;30:1307-439.
24. Wangsiripaisan A, Gengaro PE, Edelstein CL, Schrier RW. Role of polymeric Tamm-Horsfall protein in cast formation: oligo-saccharide and tubular fluid ions. Kidney Int 2001;59:932-40.
25. Tanner GA. Nephron obstruction and tubuloglomerular feed¬back. Kidney Int (Suppl) 1982;12:S213-8.
26. Noiri E, Gailit J, Sheth D, et al. Cyclic RGD peptides ameli¬orate ischemic acute renal failure in rats. Kidney Int 1994; 46:
1050-8.
27. Brady HR, Clarkson MR, Lieberthal W. Acute renal failure. In Brenner BM (eds): Brenner and Rector's The Kidney, 7th ed.
Philadelphia, Saunders, 2004, pp 1215-1292.
Official Journal of the Turkish Society of Nephrology / Türk Nefroloji Diyaliz ve Transplantasyon Dergisi
21
0 Pathophysiology of Ischemic and Toxic Tubular Necrosis
28. Toda N, Takahashi T, Mizobuchi S, et al. Tin chloride pretre-atment prevents renal injury in rats with ischemic acute renal
failure. Crit Care Med 2002;30:1512-22.
29. Brouard S, Otterbein LE, Anrather J, et al. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med 2000;192:1015-26.
30. Noiri E, Peresleni T, Miller F, Goligorsky MS. In vivo targe¬ting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia. J Clin Invest 1996;97:
2377-83.
31. Yu L, Gengaro PE, Niederberger M, Burke TJ, Schrier RW. Nitric oxide: a mediator in rat tubular hypoxia/reoxygenation injury. Proc Natl Acad Sci USA 1994;91:1691-5.
32. Noiri E, Nakao A, Uchida K, et al. Oxidative and nitrosative stress in acute renal ischemia. Am J Physiol Renal Physiol 2001;281:F948-57.
33. Chiao H, Kohda Y, McLeroy P, Craig L, Housini I, Star RA. Alp-ha-melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. J Clin Invest 1997;99: 1165-72.
34. Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med 2004;351:159-69.
35. Millar CG, Thiemermann C. Intrarenal haemodynamics and renal dysfunction in endotoxaemia: effects of nitric oxide synthase inhibition. Br J Pharmacol 1997;121:1824-30.
36. Brune B. Nitric oxide and apoptosis in mesangial cells. Kid¬ney Int 2002;61:786-9.
37. Walker LM, Walker PD, Imam SZ, Ali SF, Mayeux PR. Eviden¬ce for peroxynitrite formation in renal ischemia-reperfusion injury: studies with the inducible nitric oxide synthase inhibi¬tor L-N(6)-(1-Iminoethyl)lysine. J Pharmacol Exp Ther 2000;
295:417-22.
38. Bonventre JV, Zuk A. Ischemic acute renal failure: an inflam¬matory disease? Kidney Int 2004;66:480-5.
39. Combe C, Burton CJ, Dufourco P, et al. Hypoxia induces in¬tercellular adhesion molecule-1 on cultured human tubular cells. Kidney Int 1997;51:1703-9.
40. Ishibashi N, Weisbrot-Lefkowitz M, Reuhl K, Inouye M, Mi-rochnitchenko O. Modulation of chemokine expression du¬ring ischemia/reperfusion in transgenic mice overproducing human glutathione peroxidases. J Immunol 1999;163:5666-77.
41. Donnahoo KK, Meng X, Ayala A, Cain MP, Harken AH, Meld-rum DR. Early kidney TNF-alpha expression mediates neut-rophil infiltration and injury after renal ischemia-reperfusion. Am J Physiol 1999;277:R922-9.
42. Rabb H, Daniels F, O'Donnell M, et al. Pathophysiological ro¬le of T lymphocytes in renal ischemia-reperfusion injury in
mice. Am J Physiol Renal Physiol 2000;279:F525-31.
43. Yokota N, Daniels F, Crosson J, Rabb H. Protective effect of T cell depletion in murine renal ischemia-reperfusion injury.
Transplantation 2002;74:759-63.
44. Haller H, Dragun D, Miethke A, et al. Antisense oligonucle-otides for ICAM-1 attenuate reperfusion injury and renal fa¬ilure in the rat. Kidney Int 1996;50:473-80.
45. Rabb H, Mendiola CC, Dietz J, et al. Role of CD11a and CD11b in ischemic acute renal failure in rats. Am J Physiol 1994;267:F1052-8.
46. Takada M, Chandraker A, Nadeau KC, Sayegh MH, Tilney NL.
The role of the B7 costimulatory pathway in experimental
cold ischemia/reperfusion injury. J Clin Invest 1997;100:1199-
203.
47. Lieberthal W. Biology of ischemic and toxic renal tubular cell injury: role of nitric oxide and the inflammatory response.
Curr Opin Nephrol Hypertens 1998;7:289-95.
48. Yamamoto K, Tomita N, Yoshimura S, et al. Hypoxia-indu-ced renal epithelial cell death through caspase-dependent pathway: role of Bcl-2, Bcl-xL and Bax in tubular injury. Int J Mol Med 2004;14:633-40.
49. Kelly KJ, Plotkin Z, Dagher PC. Guanosine supplementation reduces apoptosis and protects renal function in the setting of ischemic injury. Clin Invest 2001108:1291-8.
50. Guo R, Wang Y, Minto AW, Quigg RJ, Cunningham PN. Acu¬te renal failure in endotoxemia is dependent on caspase ac¬tivation. J Am Soc Nephrol 2004;15:3093-102.
51. Wang W, Faubel S, Ljubanovic D, et al. Endotoxemic acute renal failure is attenuated in caspase-1-deficient mice. Am J
Physiol Renal Physiol 2005;288:F997-1004.
52. Creagh EM, Conroy H, Martin SJ. Caspase-activation pathways in apoptosis and immunity. Immunol Rev 2003;193:10-21.
53. Kaushal GP, Singh AB, Shah SV. Identification of gene family of caspases in rat kidney and altered expression in ischemia-reperfusion injury. Am J Physiol 1998;274:F587-95.
54. Messmer UK, Briner VA, Pfeilschifter J. Tumor necrosis factor alpha and lipopolisaccharide induce apoptotic cell death in bovine glomerular endothelial cells. Kidney Int 1999; 55:
2322-2337.
55. Bakris GL, Burnett JC Jr. A role for calcium in radiocontrast-induced reductions in renal hemodynamics. Kidney Int
1985;27:465-8.
56. Liss P, Nygren A, Erikson U, Ulfendahl HR. Injection of low and iso-osmolar contrast medium decreases oxygen tension
in the renal medulla. Kidney Int 1998;53:698-702.
57. Ueda J, Nygren A, Hansell P, Ulfendahl HR. Effect of intrave¬nous contrast media on proximal and distal tubular hydros¬tatic pressure in the rat kidney. Acta Radiol 1993;34: 83-7.
58. Persson PB, Hansell P, Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int 2005;68:14-22.
59. Heyman SN, Reichman J, Brezis M. Pathophysiology of radi-ocontrast nephropathy: a role for medullary hypoxia. Invest Radiol 1999;34:685-91.
60. Heyman SN, Clark BA, Kaiser N, et al. Radiocontrast agents induce endothelin release in vivo and in vitro. J Am Soc
Nephrol 1992;3:58-65.
61. Wang A, Holcslaw T, Bashore TM, et al. Exacerbation of ra-diocontrast nephrotoxicity by endothelin receptor antago¬nism. Kidney Int 2000;57:1675-80.
62. Weber C, Schmitt R, Birnboeck H, et al. Pharmacokinetics and pharmacodynamics of the endothelin-receptor antago¬nist bosentan in healthy human subjects. Clin Pharmacol
Ther 1996;60:124-37.
63. Liss P, Carlsson PO, Nygren A, Palm F, Hansell P. Et-A recep¬tor antagonist BQ123 prevents radiocontrast media-induced renal medullary hypoxia. Acta Radiol 2003;44:111-7.
64. Hardiek K, Katholi RE, Ramkumar V, Deitrick C. Proximal tu¬bule cell response to radiographic contrast media. Am J
Physiol Renal Physiol 2001;280:F61-70.
65. Pflueger A, Larson TS, Nath KA, King BF, Gross JM, Knox FG.
22
Türk
Nefroloj
i Diyaliz ve Transplantasyon Dergisi /Official Journal of the Turkish Society of Nephrology
Iskemik ve Toksik Akut Tübüler Nekroz Patofizyolojisi £
Role of adenosine in contrast media-induced acute renal fa¬ilure in diabetes mellitus. Mayo Clin Proc 2000;75:1275-83.
66. Ries F, Klastersky J. Nephrotoxicity induced by cancer che¬motherapy with special emphasis on cisplatin toxicity. Am J Kidney Dis 1986;8:368-79.
67. Offerman JJ, Meijer S, Sleijfer DT, et al. Acute effects of cis-diamminedichloroplatinum (CDDP) on renal function. Can¬cer Chemother Pharmacol 1984;12:36-8.
68. Winston JA, Safirstein R. Reduced renal blood flow in early cisplatin-induced acute renal failure in the rat. Am J Physiol 1985;249:F490-6.
69. Lieberthal W, Triaca V, Levine J. Mechanisms of death indu¬ced by cisplatin in proximal tubular epithelial cells: apopto-sis vs. necrosis. Am J Physiol 1996;270:F700-8.
70. Megyesi J, Safirstein RL, Price PM. Induction of p21WAF1/CIP1/SDI1
i
n kidney tubule cells affects the cour¬se of cisplatin-induced acute renal failure. J Clin Invest 1998;
101:777-82.
71. Basnakian AG, Apostolov EO, Yin X, Napirei M, Mannherz HG, Shah SV. Cisplatin nephrotoxicity is mediated by deoxy-ribonuclease I. J Am Soc Nephrol 2005;16:697-702.
72. Ramesh G, Reeves WB. TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxi-city. J Clin Invest 2002;110:835-42.
73. Ramesh G, Reeves WB. TNFR2-mediated apoptosis and nec¬rosis in cisplatin-induced acute renal failure. Am J Physiol Re¬nal Physiol 2003;285:F610-8.
74. Baliga R, Zhang Z, Baliga M, Ueda N, Shah SV. Role of
cytochrome P-450 as a source of catalytic iron in cisplatin-in-duced nephrotoxicity. Kidney Int 1998;54:1562-9.
75. Masuda H, Tanaka T, Takahama U. Cisplatin generates supe-roxide anion by interaction with DNA in a cell-free system.
Biochem Biophys Res Commun 1994;203:1175-80.
76. Liu H, Baliga R. Cytochrome P450 2E1 null mice provide no¬vel protection against cisplatin-induced nephrotoxicity and
apoptosis. Kidney Int 2003;63:1687-96.
77. Fukuoka K, Takeda M, Kobayashi M, et al. Distinct interle-ukin-1beta-converting enzyme family proteases mediate cisp-latin- and staurosporine-induced apoptosis of mouse proxi¬mal tubule cells. Life Sci 1998;62:1125-38.
78. Shiraishi F, Curtis LM, Truong L, et al. Heme oxygenase-1 ge¬ne ablation or expression modulates cisplatin-induced renal tubular apoptosis. Am J Physiol Renal Physiol 2000;
278:F726-36.
79. Dubourg L, Michoudet C, Cochat P, Baverel G. Human kid¬ney tubules detoxify chloroacetaldehyde, a presumed neph-rotoxic metabolite of ifosfamide. J Am Soc Nephrol 2001;12:
1615-23.
80. Clive DM. Renal syndromes associated with nonsteroidal an-
tiinflammatory drugs. N Engl J Med 1984; 310:563-72.
81. Ichihara A, Imig JD, Inscho EW, Navar LG. Cyclooxygenase-2 participates in tubular flow-dependent afferent arteriolar to¬ne: interaction with neuronal NOS. Am J Physiol 1998;275:
F605-12.
82. Cooper K, Bennet WM: Nephrotoxicity of common grugs used in clinical practice. Arch Intern Med 1987;147:1213-
1218.
83. Takano M, Ohishi Y, Okuda M, Yashuhama M, Hari R: Trans-
port of gentamicin and fluid phase endocytosis markers in the LLC-PK1 kidney epithelial cell line. J Pharmacol Exp Ther
1994;268:669-675.
84. Sastrasink M, Weinberg JM, Humes HS. The effect of genta-icin on calcium uptake by renal mithocondria. Life Sci
1982;30:2309-15.
85. Blaris A, Baleynoud MJ, Friad Lander G, Le-Girellae C:Primary culture of rabbit proximal tubules as acellular model to study nephrotoxicity of xenobiotics. Kidney Int 1993;44:13-18.
86. Kaloyanides GJ. Metabolic interactions between drugs and renal tubulointerstitial cells: role in nephrotoxicity: Kidney
Int 1991;39:531-540.
87. Simmons CF, Bogusky RT, Humes HD. Inhibitory effects of gentamicin on renal mitochondrial oxidative phosphorylati-
on. J Pharmacol Exp Ther 1980;214:709-715.
88. Rayson BM. Rate of synthesis and degredation of Na-K AT-Pase during chronic oubain treatment. J Biol Chem 1993;268:
8851-8854.
89. Appel GB. Aminoglycoside nephrotoxicity. Am J Med 1990;
88(suppl 3C):16S-20S.
90. Sawaya BP, Weihprecht H, Campbell WR, Lorenz JN, Webb
RC, Briggs JP, Schnermann J. Direct vasoconstriction as a possible cause for amphotericin B-induced nephrotoxicity in
rats. J Clin Invest 1991;87:2097-107.
91. Branch RA. Prevention of amphotericin B-induced renal im¬pairment. A review on the use of sodium supplementation.
Arch Intern Med 1988;148:2389-94.
92. Varlam DE, Siddiq MM, Parton LA, Russmann H. Apoptosis contributes to amphotericin B-induced nephrotoxicity. Anti-
microb Agents Chemother 2001;45(3):679-85.
93. Lieberthal W, Levine JS. Mechanisms of apoptosis and its po¬tential role in renal tubular epithelial cell injury. Am J Physi-
ol 1996;271:F477-88.
94. Lachaal M, Venuto RC. Nephrotoxicity and hyperkalemia in patients with acquired immunodeficiency syndrome treated
with pentamidine. Am J Med 1989;87:260-3.
95. Appel GB, Neu HC: The nephrotoxicity of antimicrobial
agents. N Engl J Med 1977;296: 784-787.
96. Novick AC, Hwei HH, Steinmuller D, et al. Detrimental effect of cyclosporine on initial function of cadaver renal allografts following extended preservation. Results of a randomized prospective study. Transplantation 1986;42:154-8.
97. Lanese DM, Conger JD. Effects of endothelin receptor anta¬gonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles. J Clin Invest 1993;91:2144-9.
98. Takenaka T, Hashimoto Y, Epstein M. Diminished acetylcho-line-induced vasodilation in renal microvessels of cyclospori-
ne-treated rats. J Am Soc Nephrol 1992;3:42-50.
99. De Nicola L, Thomson SC, Wead LM, Brown MR, Gabbai FB.
Arginine feeding modifies cyclosporine nephrotoxicity in
rats. J Clin Invest 1993;92:1859-65.
100. Ruggenenti P, Perico N, Mosconi L, et al. Calcium channel blockers protect transplant patients from cyclosporine-in-duced daily renal hypoperfusion. Kidney Int 1993;43:706-
11.
101. Vanholder R, Sever MS, Erek E, Lameire N. Rhabdomyolysis. J Am Soc Nephrol 2000;11:1553-61.
102. Zager RA, Gamelin LM. Pathogenetic mechanisms in experi-
Official Journal of the Turkish Society of Nephrology/ Türk Nefroloji Diyaliz ve Transplantasyon Dergisi
23
0 Pathophysiology of Ischemic and Toxic Tubular Necrosis
mental hemoglobinuric acute renal failure. Am J Physiol 1989;256:F446-55.
103. Zager RA, Foerder CA. Effects of inorganic iron and myoglo-bin on in vitro proximal tubular lipid peroxidation and cyto-toxicity. J Clin Invest 1992;89:989-95.
104. Nath KA, Balla G, Vercellotti GM, Balla J, Jacob HS, Levitt
MD, Rosenberg ME. Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest
1992;90:267-70.
105.Nakahira K, Takahashi T, Shimizu H, et al. Protective role of heme oxygenase-1 induction in carbon tetrachloride-induced hepatotoxicity. Biochem Pharmacol 2003;66:1091-105.
106.Sengul S, Batuman V. Renal involvement in multiple myelo¬ma: new insights into mechanisms. Turk J Haematol 2004; 21:59-70.
107.Smolens P, Venkatachalam M, Stein JH. Myeloma kidney cast nephropathy in a rat model of multiple myeloma. Kidney Int
1983;24:192-204.